Series B startup

Who invested in Design Therapeutics

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$125Mraised across 1 round since 2021, from 1 source

Latest round
Series B, $125MJan 2021
Investors
5
See who backed them

The rounds

  1. Jan 2021
    Series B$125M

    Source recordedSEC filing: $125M sold, first sale Jan 2021

Everyone who backed them

RA Capital ManagementPrivate equity1round
BlackRockAsset manager1round
Cormorant Asset ManagementPrivate equity1round
Vivo CapitalPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Design Therapeutics

Who invested in Design Therapeutics?

Design Therapeutics's investors include RA Capital Management, Wellington Management, BlackRock, Cormorant Asset Management and Vivo Capital.

How much has Design Therapeutics raised?

Design Therapeutics has raised $125M across 1 round since 2021.

When did Design Therapeutics last raise?

Design Therapeutics's most recent round was a Series B of $125M in Jan 2021.

What was Design Therapeutics's biggest round?

Its most recent round, $125M in Jan 2021, is also its largest on record.

Who backed Design Therapeutics first?

Design Therapeutics's first round on record, in Jan 2021, was backed by RA Capital Management, Wellington Management and BlackRock and 2 others.

What stage is Design Therapeutics at?

Design Therapeutics's latest named round is a Series B, in Jan 2021.

Companies like Design Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.